A Canadian perspective.

@article{Otten1998ACP,
  title={A Canadian perspective.},
  author={Nicolaas Otten},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={1998},
  volume={1 4},
  pages={218-23}
}
  • Nicolaas Otten
  • Published 1998 in
    Value in health : the journal of the…
Although the healthcare program in Canada is in many ways universal, there are several differences between the provinces. Two key federal bodies (the Health Protection Branch of Health Canada and the Patented Medicine Prices Review Board) are involved in the drug review process. In addition, the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), an organization funded jointly by provinces and the federal government, reviews new or existing drugs at the request of provinces… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

Evaluating the Cost-effectiveness of Pharmaceuticals in Canada

Réformes de Santé, Katherine Boothe
2016
View 13 Excerpts
Highly Influenced

Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique • 2007
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…